Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 10/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | ACHE | P22303 | 2/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | ESR1 | P03372 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PDE4B | Q07343 | 9/20 | 0.74 |
| ▸ | PDE4C | Q08493 | 9/20 | 0.74 |
| ▸ | PDE4D | Q08499 | 9/20 | 0.74 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.74 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.74 |
| ▸ | TNF | P01375 | 2/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7800905 | 0.99 | PDE4A (0.98) | PDE4ALMNACYP1A2NFKB1ACHE | |
| SCHEMBL7798793 | 0.96 | PDE4A (0.93) | PDE4ALMNACYP1A2NFKB1ACHE | |
| SCHEMBL7800864 | 0.95 | PDE4A (0.91) | PDE4ALMNACYP1A2NFKB1ACHE | |
| SCHEMBL10788889 | 0.94 | PDE4A (0.89) | PDE4ALMNACYP1A2NFKB1ACHE | |
| SCHEMBL11347084 | 0.94 | PDE4A (0.89) | PDE4ALMNACYP1A2NFKB1ACHE | |
| SCHEMBL11345748 | 0.94 | PDE4A (0.89) | PDE4ALMNACYP1A2NFKB1ACHE | |
| SCHEMBL11337820 | 0.94 | PDE4A (0.89) | PDE4ALMNACYP1A2NFKB1ACHE | |
| SCHEMBL7802032 | 0.94 | PDE4A (0.88) | PDE4ALMNACYP1A2NFKB1ACHE | |
| Propentofylline SCHEMBL28086100 | 0.93 | PDE4A (0.86) | PDE4ALMNACYP1A2NFKB1ACHE | |
| Propentofylline SCHEMBL9027889 | 0.93 | PDE4A (0.86) | PDE4ALMNACYP1A2NFKB1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4800 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122017251-A | Marker group for sarcopenia screening and diagnosis and application thereof | 四川大学华西医院 | 2026-05-12 | — | — | CN | claimed |
| US-12605345-B2 | Transdermal drug delivery system | BioPhysics Pharma, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| EP-3258950-B1 | ALZHEIMER ABETA PEPTIDE BINDING POLYPEPTIDE | AMYLONIX AB (SE) | 2025-10-29 | — | — | EP | claimed |
| US-20250268841-A1 | Trans-Epithelial Membrane Drug Delivery System | Masiz, John J. (US) | 2025-08-28 | — | — | US | claimed |
| US-12280057-B2 | Vasoactive topical compound to affect tissue blood flow, reduce tissue necrosis and promote healing | SOUTH DAKOTA BOARD OF REGENTS (US) | 2025-04-22 | — | — | US | claimed |
| US-20250120907-A1 | Transmucosal Drug Delivery System | Masiz, John J. (US) | 2025-04-17 | — | — | US | claimed |
| US-12246098-B2 | Trans-epithelial membrane drug delivery system | BioPhysics Pharma, Inc. (US) | 2025-03-11 | — | — | US | claimed |
| WO-2025046257-A1 | A SUBSTANTIALLY PURE PROPENTOFYLLINE AND PREPARATION THEREOF | HIKAL LIMITED (IN) | 2025-03-06 | — | — | WO | claimed |
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | HOTH THERAPEUTICS, INC. | 2025-01-30 | — | — | US | claimed |
| US-12133838-B2 | Homotaurine-enriched compositions and methods of use for animal health | FB MARIA SRL (IT) | 2024-11-05 | — | — | US | claimed |
| EP-0069958-B2 | Method for the preparation of gastro compatible pharmaceutical forms of xanthine derivatives. | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-03-27 | — | — | EP | claimed |
| CN-1048659-A | The preparation method of aqueogel and xerogel preparation | HOECHST JAPAN (JP) | 1991-01-23 | — | — | CN | claimed |
| EP-0386688-A1 | Method for preparing hydrogel preparations and xerogel preparations | HOECHST JAPAN LIMITED (JP) | 1990-09-12 | — | — | EP | claimed |
| EP-0169466-B1 | MIXTURE OF XANTHIN DERIVATIVES AND O-ACETYL-SALICYLIC ACID, OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS, AND ITS USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-04-04 | — | — | EP | claimed |
| EP-0305743-A2 | Pharmaceutical mixture preparation, its manufacture and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-03-08 | — | — | EP | claimed |
| US-4719212-A | ALZHEIMER'S DISEASE | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-01-12 | — | — | US | claimed |
| EP-0208962-A2 | Combination preparations from thrombocyte aggregation inhibitors, and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-01-21 | — | — | EP | claimed |
| US-4636507-A | Host defense mechanism enhancement | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1987-01-13 | — | — | US | claimed |
| EP-0069958-B1 | Method for the preparation of gastro compatible pharmaceutical forms of xanthine derivatives. | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-04-02 | — | — | EP | claimed |
| US-4542011-A | PROTECTIVE COATINGS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-09-17 | — | — | US | claimed |